is tirzepatide getting banned Regulator acts to close loophole enabling Australian pharmacists to make copycat Ozempic drug FDA Announces End To Compounded
Description
L., et al., Cardiovascular, Mortality, and Kidney Outcomes With GLP1 Receptor Agonists in Patients With Type 2 Diabetes: A Systematic Review and MetaAnalysis of Randomised Trials, Lancet Diabetes & Endocrinology 9, no

If you have type 2 diabetes, your doctor may recommend Bydureon BCise as a treatment
The risk in humans is still unknown

Coverage for off-label use is challenging
Its essential to inform us of any changes

So if you are currently somewhere in the middle of that process: keep going Full Paper: More work on deprescribing, including evidence from #Austria, is already on the way
